"Illumina has set the standard in whole genome sequencing, and now, with Broad's deep experience and long history of translating complex molecular biology assays into high-throughput, high quality ...

Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically ...

This is the new Illumina assay panel Angle have spent 6 months working with Illumina on for the dual analysis of CTC-DNA and ctDNA. "Findings in lung cancer show that CTCs can provide additional ...

Broad Clinical Labs is experienced, with a long history of translating complex molecular biology assays into high-throughput, quality workflows. Illumina is doing the same with single-cell ...

"Illumina has set the standard in whole genome sequencing, and now, with Broad's deep experience and long history of translating complex molecular biology assays into high-throughput, high quality ...

The pilot program is based on Illumina's upcoming proteomics assay, Illumina Protein Prep™, powered by SOMAmer® technology, a next-generation sequencing (NGS) based solution that will help ...

Mammalian genomes are organized by multi-level folding, yet how this organization contributes to cell type-specific transcription remain unclear. We uncovered that the nuclear protein SATB1 ...

The global DNA diagnostics market is on an impressive growth trajectory, with sales projected to reach USD 27,094.2 million in 2024, and further expanding to USD 57,420.1 million by 2034. This surge ...

Illumina, Inc. ILMN recently entered into a collaboration with Broad Clinical Labs to rapidly streamline and scale single-cell projects with cutting-edge tools and workflows. Together, the companies ...